Ignite Creation Date:
2024-05-06 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05719324
Status:
RECRUITING
Last Update Posted:
2023-02-10
First Post:
2023-01-31
Brief Title:
Checkpoint Inhibitors in Patients With Solid Tumors a Retrospective Real-world Study
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
The First Affiliated Hospital with Nanjing Medical University
Study Overview
Official Title:
Checkpoint Inhibitors in Patients With Solid Tumors a Retrospective Real-world Study
Status:
RECRUITING
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a retrospective clinical study aimed at observing and evaluating the effectiveness and safety of checkpoint inhibitors in the treatment of patients with solid tumors in actual clinical applications To explore predictors of efficacy patients with unresectable solid tumors receiving checkpoint inhibitors and develop and further validate predictive models
Detailed Description:
The clinical data of patients with unresectable solid tumors were collected retrospectively who received two or more cycles of checkpoint inhibitor therapy The progression-free survival PFS overall survival OS and related adverse reactions of the patients were followed up To screen prognostic factors develop predictive models and visualize them as nomograms
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None